BIOSINO BIO-TEC (08247) signed a strategic cooperation agreement with Xiaoshou Medical, to jointly promote the sinking of high-quality medical resources and the improvement of primary medical service capabilities.

BIOSINO BIO-TEC (08247) announced that on February 11, 2026, the company and Guangdong Xiaoshou Medical Technology Co., Ltd. (Xiaoshou Medical) officially signed a strategic cooperation agreement in Beijing. The two parties will cooperate in multiple dimensions in the field of grassroots medical care to promote the sinking of quality medical resources and the improvement of grassroots medical service capabilities. According to the strategic cooperation agreement, the company and Xiaoshou Medical will explore the following cooperation directions: (1) Capital and Strategic Synergy The company plans to make a strategic investment in Xiaoshou Medical, establish a long-term stable strategic cooperation relationship, and explore deepening cooperation based on capital as a link, jointly exploring innovative development models in the grassroots medical market. (2) Business and Resource Complementarity The group will leverage its product advantages and research and development capabilities in the in-vitro diagnostics (IVD) field, combined with Xiaoshou Medical's nationwide grassroots medical channel network and digital platform, to promote the direct reach of biochemical, immunological, POCT, and other products and overall solutions to grassroots medical institutions. The two parties will also strengthen data insights, product development, and supply chain optimization in a compliant and data-desensitized manner. They will establish a joint working group to develop customized products and overall solutions for the grassroots medical scene. (3) Ecological and Value Co-creation The two parties will integrate equipment, reagents, operations, data, and other multidimensional resources to provide one-stop testing service solutions for regional medical communities and chain clinics, enhancing the overall testing capabilities and operational efficiency of grassroots medical institutions. The cooperation will be steadily promoted in stages, starting from strategic pilot verification and gradually expanding to large-scale implementation, further exploring deep coordination at the industrial and capital levels. The board believes that the strategic cooperation with Xiaoshou Medical will help the group integrate high-quality research and development capabilities with digital channel resources, accelerate product and service penetration into grassroots medical institutions, and align with the national direction of promoting the construction of the grassroots medical system and the "Healthy China" strategy. The board believes that the cooperation planned under the strategic cooperation agreement will help expand the group's market coverage, enhance brand influence and long-term competitiveness, and align with the overall interests of the company and its shareholders.